Related Experiment Video
Updated: Jan 13, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
[Chagas Disease in Spain: Update, Recommendations, and Screening Protocols for Nationwide Control]
M B Roldán Rodríguez1, R Pérez Tanoira2, M Pérez Butragueño3
1Escuela de Doctorado, Área de Ciencias de la Salud, Universidad de Alcalá de Henares, Alcalá de Henares, España; Centro de Salud El Casar, SESCAM, Guadalajara, España; Departamento de Pediatría, CUF Belém y Miraflores, Lisboa, Portugal.
None:
Chagas disease (CD), endemic in 21 Latin American countries, affects 6-7 million people worldwide, causes approximately 12,000 deaths annually, and leads to 9,000 newborns being infected through vertical transmission. Spain is the European country with the highest number of cases, with vertical transmission being the main route of infection in our setting. Although most infected individuals are asymptomatic, around 30% will develop Chagas cardiomyopathy over time, which carries an annual mortality rate of approximately 4%. The effectiveness of treatment decreases as the duration of infection and the patient's age increase. Once cardiac involvement is established, treatment neither reverses the damage nor halts disease progression. Therefore, screening programs are of vital importance. In 2024, the Spanish Ministry of Health published a national consensus document on prenatal screening for Chagas disease, applicable across the entire national territory.
Related Concept Videos
Principles of Disease Surveillance
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

